Cargando…
B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012119/ http://dx.doi.org/10.1097/01.HS9.0000829564.55849.0d |
| _version_ | 1784687735207886848 |
|---|---|
| author | Mateos, M Hari, P Bahlis, N Chari, A van de Donk, NWCJ Dholaria, B Garfall, AL Goldschmidt, H Kortüm, KM Krishnan, A Martin, T Morillo, D Oriol, A Reece, D Rodriguez, C Rodríguez-Otero, P San-Miguel, JF Usmani, SZ Verona, R Lin, SXW Prior, TJ Wade, M Weiss, B Goldberg, JD Askari, E |
| author_facet | Mateos, M Hari, P Bahlis, N Chari, A van de Donk, NWCJ Dholaria, B Garfall, AL Goldschmidt, H Kortüm, KM Krishnan, A Martin, T Morillo, D Oriol, A Reece, D Rodriguez, C Rodríguez-Otero, P San-Miguel, JF Usmani, SZ Verona, R Lin, SXW Prior, TJ Wade, M Weiss, B Goldberg, JD Askari, E |
| author_sort | Mateos, M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9012119 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90121192022-04-18 B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS Mateos, M Hari, P Bahlis, N Chari, A van de Donk, NWCJ Dholaria, B Garfall, AL Goldschmidt, H Kortüm, KM Krishnan, A Martin, T Morillo, D Oriol, A Reece, D Rodriguez, C Rodríguez-Otero, P San-Miguel, JF Usmani, SZ Verona, R Lin, SXW Prior, TJ Wade, M Weiss, B Goldberg, JD Askari, E Hemasphere Best Abstracts - Oral Presentations Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9012119/ http://dx.doi.org/10.1097/01.HS9.0000829564.55849.0d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Best Abstracts - Oral Presentations Mateos, M Hari, P Bahlis, N Chari, A van de Donk, NWCJ Dholaria, B Garfall, AL Goldschmidt, H Kortüm, KM Krishnan, A Martin, T Morillo, D Oriol, A Reece, D Rodriguez, C Rodríguez-Otero, P San-Miguel, JF Usmani, SZ Verona, R Lin, SXW Prior, TJ Wade, M Weiss, B Goldberg, JD Askari, E B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS |
| title | B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS |
| title_full | B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS |
| title_fullStr | B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS |
| title_full_unstemmed | B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS |
| title_short | B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS |
| title_sort | b06: subcutaneous talquetamab in combination with daratumumab in patients with relapsed/refractory multiple myeloma (rrmm): phase 1b results |
| topic | Best Abstracts - Oral Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012119/ http://dx.doi.org/10.1097/01.HS9.0000829564.55849.0d |
| work_keys_str_mv | AT mateosm b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT harip b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT bahlisn b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT charia b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT vandedonknwcj b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT dholariab b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT garfallal b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT goldschmidth b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT kortumkm b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT krishnana b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT martint b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT morillod b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT oriola b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT reeced b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT rodriguezc b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT rodriguezoterop b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT sanmigueljf b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT usmanisz b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT veronar b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT linsxw b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT priortj b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT wadem b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT weissb b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT goldbergjd b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults AT askarie b06subcutaneoustalquetamabincombinationwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmphase1bresults |